Prostaglandin E2 both stimulates and inhibits adenyl cyclase on platelets: Comparison of effects on cloned EP4 and EP3 prostaglandin receptor subtypes

Prostaglandins

Volumn 52, Issue 3, 1996, Pages 175-185

  Mao, G F ^a   Jin, J G ^a   Bastepe, M ^a   Ortiz Vega, S ^a   Ashby, B ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; BUTAPROST; CYCLIC AMP; FORSKOLIN; ILOPROST; ISOBUTYLMETHYLXANTHINE; PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; RECEPTOR SUBTYPE; SULPROSTONE; ANTITHROMBOCYTIC AGENT; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2 RECEPTOR, EP4 SUBTYPE; PROSTAGLANDIN EP3 RECEPTOR;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; MOLECULAR CLONING; NONHUMAN; THROMBOCYTE METABOLISM; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG ANTAGONISM; GENETICS; HAMSTER; HUMAN; METABOLISM; THROMBOCYTE;

ANIMALIA;

ADENYLATE CYCLASE; ANIMALS; BLOOD PLATELETS; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; CYCLIC AMP; DINOPROSTONE; FORSKOLIN; HUMANS; ILOPROST; PLATELET AGGREGATION INHIBITORS; RECEPTORS, PROSTAGLANDIN E;

EID: 0030222502     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(96)00095-0     Document Type: Article

References (19)

1. 1. Mills DCB (1982) The role of cyclic nucleotides in platelets In: Kebabian JW, Nathanson JA, eds. Handbook of Experimental Pharmacology, Volume 58/II Springer-Verlag: 732-761.
2. 2. Macintyre DE (1981) Platelet prostaglandin receptors. In: Gordon JL, ed. Platelets in biology and Pathology 2. Elsevier/North-Holland Biomedical Press. : 211-247.
3. 3. Ashby B (1986) Kinetic evidence indicating separate stimulatory and inhibitory prostaglandin receptors on platelet membranes. J Cyc Nucl Prot Phos Res. 11: 291-300.
4. 4. Ashby B (1988) cAMP turnover in response to prostaglandins in intact platelets: evidence for separate stimulatory and inhibitory prostaglandin receptors. Second Messengers & Phosphoproteins 12: 45-57.
5. 5. Ashby B (1989) Model of prostaglandin regulated cAMP metabolism in platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities. Mol Pharmacol 36: 866-873.
6. 6. Ashby B (1990) Novel mechanism of heterologous desensitization of adenylate cyclase: Prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets. Mol Pharmacol 38:46-53.
7. 2 subtype from human erythroleukemia cells Abstract. International Congress of Pharmacology, Montreal.
8. 8. Kunapuli SP, Mao GF, Bastepe M, Liu-Chen L, Li S, Cheung PP, DeRiel JK, Ashby B (1994) Cloning and expression of a prostaglandin E receptor EP3 subtype from human erythroleukemia cells. Biochem. J. 298: 263-267.
9. 9. Boie Y, Rushmore TH, Darmon-Goodwin A, Grygorcyzk R, Slipetz DM, Metters KM, Abramovitz M (1994) Cloning and expression of a cDNA for the human prostanoid IP receptor. J Biol Chem 269: 12173-12178.
10. 10. Katsuyama M, Sugimoto Y, Namba T, Irie A, Negishi M, Narumiya S, Ichikawa A. (1994) Cloning and expression of a cDNA for the human prostacyclin receptor. FEBS Letters 344: 74-78.
11. 11. An S, Yang J, Xia M, Goetzl EJ (1993) Cloning and expression of the EP2 subtype of human receptors for prostaglandin E2. Biochem Biophys Res Commun 197: 263-270.
12. 12. Yang J, Xia M, Goetzl EJ, An S. (1994) Cloning and expression of the EP3 subtype of human receptors for prostaglandin E2. Biochem Biophys Res Commun 198:999-1006.
13. 13. Nishigaki N, Negishi M, Honda A, Sugimoto Y, Namba T, Narumiya S, Ichikawa A. (1995) Identification of prostaglandin E receptor 'EP2' cloned from mastocytoma cells EP4 subtype. FEBS Lett 364:339-341.
14. 14. Regan JW, Bailey TJ, Pepperl DJ, Pierce KL, Bogardus AM, Donello JE, Fairbairn CE, Kedzie KM, Woodward DF, Gil DW (1994) Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Mol Pharmacol 46: 213-230.
15. 15. Regan JW, Bailey TJ, Donello JE, Pierce KL, Pepperl DJ, Zhang D, Kedzie KM, Faurbairn CE, Bogardus AM, Woodward DF et al. (1994) Molecular cloning and expression of human EP3 receptors: evidence of three variants with differing carboxyl termini. Brit J Pharmacol 112: 377-385.
16. 16. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 74: 5463-5468.
17. 17. Salomon Y. (1979) Adenylate cyclase assay. Adv Cyc Nucl Res. 10: 35-55.
18. 18. Barber R. (1988) Forskolin binding to intact S49 lymphoma cells. Second Messengers and Phosphoproteins 12: 59-71.
19. 19. Sindt KA, Hewlett EL, Redpath GT, Rappuoli R, Gray LS, Vandenburg SR (1994) Pertussis toxin activates platelets through an interaction with platelet glycoprotein Ib. Infection and Immunity 62: 3108-3114.: